SCHEMBL30118271

SCHEMBL30118271

N#Cn1c2ccccc2c2cc(-n3c4ccccc4c4ccccc43)ccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
ATM Q13315 1/20 0.47
MAPT P10636 4/20 0.34
ALDH1A1 P00352 4/20 0.34
HPGD P15428 3/20 0.34
HSD17B10 Q99714 3/20 0.34
CASP1 P29466 1/20 0.34
MEN1 O00255 2/20 0.33
HTT P42858 2/20 0.33
KMT2A Q03164 2/20 0.33
MAPK1 P28482 1/20 0.33
HBB P68871 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
GPR3 P46089 1/20 0.32
RAC2 P15153 1/20 0.32
RAC3 P60763 1/20 0.32
CDC42 P60953 1/20 0.32
RAC1 P63000 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21163201 0.87 KDM4E (0.37) KDM4EL3MBTL1ATMALDH1A1HPGD
SCHEMBL21163385 0.84 ATM (0.37) KDM4EL3MBTL1ATMMAPTALDH1A1
SCHEMBL12856812 0.84 KDM4E (0.42) KDM4EL3MBTL1ATMMAPTALDH1A1
SCHEMBL19721759 0.83 KDM4E (0.67) KDM4EL3MBTL1ATMMAPTALDH1A1
SCHEMBL16848794 0.83 KDM4E (0.67) KDM4EL3MBTL1ATMMAPTALDH1A1
SCHEMBL21578475 0.83 KDM4E (0.67) KDM4EL3MBTL1ATMMAPTALDH1A1
SCHEMBL29457635 0.83 KDM4E (0.67) KDM4EL3MBTL1ATMMAPTALDH1A1
SCHEMBL8739919 0.81 KDM4E (0.50) KDM4EL3MBTL1ATMMAPTALDH1A1
SCHEMBL18347415 0.81 KDM4E (0.50) KDM4EL3MBTL1ATMMAPTALDH1A1
SCHEMBL23264343 0.81 KDM4E (0.58) KDM4EL3MBTL1ATMMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11575088-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2023-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11575088-B2 Composition of matter for use in organic light-emitting diodes CRY2, CYBA, ALDH1A2 KDM4E 4556/4885L3MBTL1 1186/4885ATM 2253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.